Quick Answer
Kiniksa Pharmaceuticals International, plc reported Stockholders Equity of $567.61 million for fiscal year 2025.
Kiniksa Pharmaceuticals International, plc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $567.61M | +29.5% |
| 2024 | $438.44M | -0.1% |
| 2023 | $438.84M | +10.8% |
| 2022 | $396.15M | +114.1% |
| 2021 | $185.04M | -40.7% |
| 2020 | $311.94M | +38.4% |
| 2019 | $225.42M | -19.3% |
| 2018 | $279.27M | +411.3% |
| 2017 | -$89.71M | -248.6% |
| 2016 | -$25.73M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $535.38M | +22.5% | +8.2% |
| June 30, 2025 | $495.01M | +13.8% | +8.2% |
| March 31, 2025 | $457.49M | +5.9% | +4.3% |
| December 31, 2024 | $438.44M | -0.1% | +0.3% |
| September 30, 2024 | $437.01M | +7.9% | +0.4% |
| June 30, 2024 | $435.10M | +5.7% | +0.7% |
| March 31, 2024 | $431.89M | +10.7% | -1.6% |
| December 31, 2023 | $438.84M | +10.8% | +8.3% |
- Kiniksa Pharmaceuticals International, plc showed an increase of +29.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Kiniksa Pharmaceuticals International, plc’s stockholders equity has grown by 2305.8% (from -$25.73 million to $567.61 million).
- The most recent figure is from Kiniksa Pharmaceuticals International, plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: